BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2932107)

  • 41. A kinetic model of phosphofructokinase from Plasmodium berghei. Influence of ATP and fructose-6-phosphate.
    Buckwitz D; Jacobasch G; Gerth C; Holzhütter HG; Thamm R
    Mol Biochem Parasitol; 1988 Jan; 27(2-3):225-32. PubMed ID: 2963958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photoaffinity labeling and photoaffinity cross-linking of phosphofructokinase-1 from Saccharomyces cerevisiae by 8-azidoadeninenucleotides.
    Knoche M; Mönnich K; Schäfer HJ; Kopperschläger G
    Arch Biochem Biophys; 2001 Jan; 385(2):301-10. PubMed ID: 11368011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphofructokinase from Plasmodium berghei. Influence of Mg2+, ATP and Mg2(+)-complexed ATP.
    Buckwitz D; Jacobasch G; Gerth C
    Biochem J; 1990 Apr; 267(2):353-7. PubMed ID: 2139776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of phosphofructokinase behavior by chemical modifications during the immobilization process.
    Cambou B; Laurent M; Hervagault JF; Thomas D
    Eur J Biochem; 1981 Dec; 121(1):99-104. PubMed ID: 6459932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of temperature change on the kinetic behaviour of yeast phosphofructokinase.
    Nissler K; Schellenberger W; Wolf J; Hofmann E
    Acta Biol Med Ger; 1976; 35(10):1273-7. PubMed ID: 139067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Properties of phosphofructokinase from the mucosa of rat jejunum and their relation to the lack of Pasteur effect.
    Tejwani GA; Ramaiah A
    Biochem J; 1971 Nov; 125(2):507-14. PubMed ID: 4259410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of trypsin on yeast phosphofructokinase.
    Freyer R; Böhme HJ; Hofmann E
    Acta Biol Med Ger; 1974; 32(6):593-9. PubMed ID: 4278551
    [No Abstract]   [Full Text] [Related]  

  • 48. A conformational transition involved in antagonistic substrate binding to the allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Garel JR
    Biochemistry; 1992 Feb; 31(6):1695-700. PubMed ID: 1531298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of D-fructose and fructose 1-phosphate with yeast phosphofructokinase and its influence on glycolytic oscillations.
    Kreuzberg K
    Biochim Biophys Acta; 1978 Nov; 527(1):229-38. PubMed ID: 152653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chicken liver phosphofructokinase. 3. Kinetics and allosteric properties.
    Kono N; Uyeda K
    J Biol Chem; 1974 Mar; 249(5):1490-6. PubMed ID: 4361737
    [No Abstract]   [Full Text] [Related]  

  • 51. Modification of yeast phosphofructokinase with pyridoxal 5'-phosphate.
    Reuter R; Sellschopp I; Xyländer C; Hofmann E
    Biomed Biochim Acta; 1983; 42(9):1067-77. PubMed ID: 6231021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Yeast phosphofructokinase: pre-steady-state and stationary kinetic studies on a cross-linked enzyme form.
    Kriegel T; Bär J; Schellenberger W; König S; Behlke J; Hübner G; Kopperschläger G
    Biomed Biochim Acta; 1990; 49(5):317-25. PubMed ID: 2148671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors.
    Van Schaftingen E; Jett MF; Hue L; Hers HG
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3483-6. PubMed ID: 6455662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ligand-induced conformational transitions in Escherichia coli phosphofructokinase 2: evidence for an allosteric site for MgATP2-.
    Guixé V; Rodríguez PH; Babul J
    Biochemistry; 1998 Sep; 37(38):13269-75. PubMed ID: 9748334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solution X-ray scattering studies of the yeast phosphofructokinase allosteric transition. Characterization of an ATP-induced conformation distinct in quaternary structure from the R and T states of the enzyme.
    Laurent M; Tijane MN; Roucous C; Seydoux FJ; Tardieu A
    J Biol Chem; 1984 Mar; 259(5):3124-6. PubMed ID: 6230356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation by phosphate of yeast phosphofructokinase.
    Bañuelos M; Gancedo C; Gancedo JM
    J Biol Chem; 1977 Sep; 252(18):6394-8. PubMed ID: 19473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of polyethylene glycols on the kinetics of rat liver phosphofructokinase.
    Reinhart GD
    J Biol Chem; 1980 Nov; 255(22):10576-8. PubMed ID: 6448853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic evidence for distinct catalytic and regulatory subunits in yeast phosphofructokinase.
    Lobo Z; Maitra PK
    FEBS Lett; 1982 Mar; 139(1):93-6. PubMed ID: 6210572
    [No Abstract]   [Full Text] [Related]  

  • 59. [Properties of erythrocyte phosphofructokinase in normal humans].
    Mandereau J; Boivin P
    Biochimie; 1973; 55(11):1341-51. PubMed ID: 4364375
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of AMP and Cibacron blue F3G-A on the fructose 6-phosphate binding of yeast phosphofructokinase.
    Nissler K; Kessler R; Schellenberger W; Hofmann E
    Biochem Biophys Res Commun; 1979 Dec; 91(4):1462-7. PubMed ID: 160797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.